On August 14, 2026, Cellebrite DI Ltd CLBT shares rose 3.1% to a current price of $11.14. This price is significantly below its 52-week high of $19.98 and above its 52-week low of $9.58, reflecting a volatile period for the stock.
- GF Valueā¢ verdict: CLBT is currently priced at $11.14, which is 30.8% below its GF Valueā¢ estimate of $16.09, indicating it is undervalued.
- GF Scoreā¢: The stock has a GF Scoreā¢ of 84/100, signifying strong fundamentals and growth potential.
- Notable signal: The momentum rank is at 10/10, suggesting strong positive price movement recently.
Is CLBT Overvalued or Undervalued?
According to the GF Valueā¢, which is GuruFocus' proprietary intrinsic-value estimate derived from historical trading multiples, past business growth, and future performance estimates, Cellebrite DI Ltd appears to be undervalued at its current price of $11.14. With a GF Valueā¢ of $16.09, there is a margin of safety of 30.8%, suggesting that the stock could be a compelling opportunity for those looking for potential upside.
Being classified as significantly undervalued, CLBT presents an opportunity for investors to consider. However, it is essential to note that the stock has experienced a considerable decline year-to-date, down 38.2%, indicating market volatility and potential risks associated with investing at this time. As always, potential investors should conduct thorough due diligence before making any decisions.
How Does CLBT's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | 50.6x | 42.1x |
| Forward P/E | 19.8x | N/A |
Currently, CLBT's P/E ratio of 50.6x is notably above its 5-year median of 42.1x, indicating that the stock is trading at a premium relative to its historical valuation. However, the forward P/E of 19.8x suggests a more favorable outlook, which aligns with the GF Valueā¢ assessment of being undervalued. This discrepancy may reflect current market sentiments rather than underlying fundamental performance.
What Does CLBT's GF Scoreā¢ Tell Us?
The GF Scoreā¢ evaluates a company's financial strength, profitability, growth, valuation, and momentum to provide a comprehensive view of its investment potential. With a GF Scoreā¢ of 84/100, CLBT demonstrates robust fundamentals, particularly in its growth rank of 9/10, signaling strong potential for future expansion. Conversely, its valuation rank stands at 4/10, indicating that while the growth prospects are promising, the current valuation may be a concern.
| Metric | Rating |
|---|---|
| GF Scoreā¢ | 84 |
| Financial Strength | 8/10 |
| Profitability | 6/10 |
| Growth | 9/10 |
| Valuation | 4/10 |
| Momentum | 10/10 |
Overall, CLBT's strong growth and financial strength metrics suggest healthy operational performance, while the lower valuation rank indicates some caution with its pricing. The high momentum score further emphasizes recent positive price trends, which could attract investors looking for stocks with upward price movement.
What Are Gurus and Insiders Doing with CLBT?
Currently, 5 gurus hold positions in CLBT, with 3 adding to their stakes and 1 trimming their position in recent quarters. This indicates a generally favorable sentiment among institutional investors, suggesting potential confidence in the stock's value proposition.
However, insider activity reflects a cautionary note, as insiders have sold $4.7 million worth of shares in the last 3 months without any buying activity. This selling may raise questions about the confidence of company executives in the stock's near-term performance, highlighting the importance of monitoring insider transactions as part of a comprehensive investment analysis.
What This Means for Investors
In conclusion, Cellebrite DI Ltd CLBT appears to be undervalued based on the GF Valueā¢ assessment, which suggests a significant upside potential. The stock's strong GF Scoreā¢ reinforces its compelling fundamentals, though caution is warranted given the recent insider selling and historical P/E ratios. Investors should closely monitor these dynamics when considering their positions.
For more detailed insights, visit the Cellebrite DI Ltd CLBT stock page and explore additional resources such as the GF Valueā¢ page or the GuruFocus Stock Screener.
Frequently Asked Questions
What is CLBT's GF Scoreā¢?
CLBT has a GF Scoreā¢ of 84/100, indicating strong fundamentals and growth potential in its business operations.
Is CLBT overvalued or undervalued?
CLBT is currently undervalued, with a GF Valueā¢ estimate suggesting a 30.8% upside from its current price.
What is CLBT's P/E ratio?
The P/E ratio for CLBT is 50.6x, which is above its 5-year median of 42.1x, indicating that the stock is trading at a premium relative to its historical valuation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
